{
    "SPADE_N_15512": {
        "Sequence Information": {
            "Peptide Name": "Nocaviogua A",
            "Sequence": "XASVSSDGC",
            "Sequence Length": 9,
            "Biological Activity": [
                "Anti-Gram+",
                "Anti-Gram-",
                "Anticancer",
                "Antifungal"
            ],
            "Binding Target": "1. Lipid II",
            "Source": "1. Nocardia sp.",
            "Gene": "",
            "PDB ID": "",
            "UniProt Entry": [],
            "Literature": [
                {
                    "Title": "Nocaviogua A and B: two lipolanthines from root-nodule-associated Nocardia sp.",
                    "Pubmed ID": "37601909",
                    "Reference": "Front Chem. 2023;11:1233938",
                    "Author": "Chang S, Luo Y, He N, Huang X, Chen M, Yuan L, Xie Y",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/37601909"
                }
            ],
            "SPADE ID": "SPADE_N_15512",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_09449",
                    "Similarity": 1.0,
                    "Sequence": "GLFDVIKKVASV"
                },
                {
                    "SPADE_ID": "SPADE_N_09454",
                    "Similarity": 1.0,
                    "Sequence": "IKKVASV"
                },
                {
                    "SPADE_ID": "SPADE_N_09460",
                    "Similarity": 1.0,
                    "Sequence": "GLFAVIKKVASV"
                }
            ],
            "Hemolytic Activity": "",
            "Target Organism": "Staphylococcus aureus ATCC 29213(no activity data),Enterococcus faecium ATCC 35667(no activity data),Escherichia coli ATCC 25922(no activity data),Klebsiella pneumoniae ATCC 700603(no activity data),Candida albicans ATCC 10231(no activity data),Candida tropicalis ATCC 1369(no activity data),Human uveal melanoma UM92-1(10-20% Inhibition=50µM),Human squamous lung carcinoma NCI-H2170(30-40% Inhibition=50µM),Human breast adenocarcinoma SK-BR-3(no activity data),Human breast adenocarcinoma MDA-MB-231(30-40% Inhibition=50µM),Human breast adenocarcinoma MDA-MB-435(10-20% Inhibition=50µM)"
        }
    }
}